|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102 TWD | +5.48% |
|
+3.45% | +16.04% |
Diamond Biotechnology Co., Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 296.3 million compared to TWD 192.89 million a year ago. Net income was TWD 29.78 million compared to TWD 17.34 million a year ago.
Basic earnings per share from continuing operations was TWD 1.082 compared to TWD 0.6304 a year ago. Diluted earnings per share from continuing operations was TWD 1.082 compared to TWD 0.6304 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.04% | 86.3M | |
| -5.60% | 181B | |
| -4.45% | 101B | |
| -4.15% | 67.54B | |
| -8.63% | 45.09B | |
| +9.70% | 44.37B | |
| +6.95% | 40.7B | |
| +15.22% | 29.85B | |
| +12.85% | 24.49B | |
| -6.46% | 23.99B |
DIAMOND BIOTECHNOLOGY CO., LTD 
